Davidson Kempner Capital Management »

Miragen Therapeutics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $366k 24k 15.34

More positions owned by Davidson Kempner Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Verona Pharma Sponsored Ads (VRNA)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Pdd Holdings Note 12/0 (Principal)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Uber Technologies Note 0.875%12/0 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Amazon (AMZN)
Arko Corp (ARKO)
Rivian Automotive Note 4.625% 3/1 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)
NVIDIA Corporation (NVDA)
Snowflake Note 10/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Miragen Therapeutics

FMR
Vanguard Group
BlackRock
Deep Track Capital
Kynam Capital Management
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics